Followers | 67 |
Posts | 4831 |
Boards Moderated | 0 |
Alias Born | 06/12/2014 |
Wednesday, October 16, 2019 11:44:29 PM
Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements
GlobeNewswireOctober 17, 2019, 2:08 AM UTC
VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE:IPOT) formerly Atlas Blockchain Group Inc. (CSE:AKE) (A49.F) (ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company has met all conditions to list on the Canadian Securities Exchange. The Company will commence trading at market open on October 17, 2019.
Isracann is an Israeli-based cannabis company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied, major European marketplaces. Based in Israel's agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research. For more information visit: www.isracann.com.
https://finance.yahoo.com/news/isracann-biosciences-announces-listing-cse-020849216.html
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM